Meridian Bioscience
Markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components.
Launch date
Employees
Market cap
€1.4b
Enterprise valuation
€1.3b (Public information from Feb 2023)
Share price
$33.97 VIVO
Cincinnati Ohio (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$5.5m | Grant | ||
$2.5m | Grant | ||
Total Funding | €7.3m |
Related Content
Recent News about Meridian Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Meridian Bioscience
EditACQUISITION by Meridian Bioscience Mar 2016
ACQUISITION by Meridian Bioscience Jul 2010
ACQUISITION by Meridian Bioscience Feb 2020
ACQUISITION by Meridian Bioscience Jul 2022
ACQUISITION by Meridian Bioscience Jul 2021